Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
CRISPR Therapeutics
CRSP
$5.2B
| $1.11M | ﹤0.01% |
17,624
+3,453
| +24% | +$217K |
|
2252
Hubbell
HUBB
$26.5B
| $1.11M | ﹤0.01% |
6,026
-6,568
| -52% | -$1.23M |
|
|
HT
2253
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.11M | ﹤0.01% |
121,883
-15,751
| -11% | -$145K |
|
|
WBT
2254
DELISTED
Welbilt, Inc.
WBT
| $1.1M | ﹤0.01% |
46,463
-225,206
| -83% | -$5.35M |
|
2255
CNX Resources
CNX
$5.28B
| $1.1M | ﹤0.01% |
52,977
-271,908
| -84% | -$4.53M |
|
2256
Qfin Holdings
QFIN
$1.65B
| $1.09M | ﹤0.01% |
71,000
-200
| -0.3% | -$3.74K |
|
|
LHCG
2257
DELISTED
LHC Group LLC
LHCG
| $1.09M | ﹤0.01% |
6,484
-49,214
| -88% | -$6.58M |
|
|
KCGI
2258
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $1.09M | ﹤0.01% |
+109,703
| New | +$1.08M |
|
2259
FTI Consulting
FCN
$4.3B
| $1.08M | ﹤0.01% |
6,864
-4,959
| -42% | -$739K |
|
2260
Planet Fitness
PLNT
$4.43B
| $1.08M | ﹤0.01% |
12,785
+8,810
| +222% | +$765K |
|
2261
NexGen Energy
NXE
$6.51B
| $1.08M | ﹤0.01% |
190,425
+27,225
| +17% | +$131K |
|
2262
Ichor Holdings
ICHR
$2.47B
| $1.08M | ﹤0.01% |
30,246
-11,986
| -28% | -$467K |
|
2263
iShares MSCI South Africa ETF
EZA
$562M
| $1.08M | ﹤0.01% |
+19,379
| New | +$996K |
|
2264
DT Midstream
DTM
$13.8B
| $1.07M | ﹤0.01% |
+19,809
| New | +$1.03M |
|
2265
Nelnet
NNI
$4.9B
| $1.07M | ﹤0.01% |
12,639
-7,968
| -39% | -$686K |
|
|
BMAC
2266
DELISTED
Black Mountain Acquisition Corp.
BMAC
| $1.07M | ﹤0.01% |
+107,981
| New | +$1.07M |
|
2267
Murphy USA
MUSA
$10.9B
| $1.07M | ﹤0.01% |
5,357
-81,529
| -94% | -$15.3M |
|
2268
Artivion
AORT
$1.31B
| $1.07M | ﹤0.01% |
50,062
-17,254
| -26% | -$333K |
|
|
XPOA
2269
DELISTED
DPCM Capital, Inc.
XPOA
| $1.07M | ﹤0.01% |
+108,287
| New | +$1.07M |
|
2270
Power Integrations
POWI
$3.6B
| $1.07M | ﹤0.01% |
11,531
-72,676
| -86% | -$6.34M |
|
2271
Enanta Pharmaceuticals
ENTA
$385M
| $1.07M | ﹤0.01% |
14,970
-10,068
| -40% | -$655K |
|
2272
Mesa Laboratories
MLAB
$569M
| $1.07M | ﹤0.01% |
4,184
-2,322
| -36% | -$631K |
|
2273
The RealReal
REAL
$1.54B
| $1.06M | ﹤0.01% |
146,558
-17,619
| -11% | -$156K |
|
2274
Amkor Technology
AMKR
$13.9B
| $1.06M | ﹤0.01% |
49,030
-99,604
| -67% | -$2.25M |
|
|
CERO
2275
DELISTED
CERo Therapeutics
CERO
| $1.06M | ﹤0.01% |
+53
| New | +$1.05M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.